6oq5: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
<StructureSection load='6oq5' size='340' side='right'caption='[[6oq5]], [[Resolution|resolution]] 3.87Å' scene=''> | <StructureSection load='6oq5' size='340' side='right'caption='[[6oq5]], [[Resolution|resolution]] 3.87Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[6oq5]] is a 4 chain structure with sequence from [ | <table><tr><td colspan='2'>[[6oq5]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Camelidae Camelidae] and [https://en.wikipedia.org/wiki/Clostridioides_difficile Clostridioides difficile]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OQ5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6OQ5 FirstGlance]. <br> | ||
</td></tr><tr id=' | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.87Å</td></tr> | ||
<tr id=' | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6oq5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6oq5 OCA], [https://pdbe.org/6oq5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6oq5 RCSB], [https://www.ebi.ac.uk/pdbsum/6oq5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6oq5 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | |||
[https://www.uniprot.org/uniprot/M4NKV9_CLODI M4NKV9_CLODI] | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 17: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 6oq5" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 6oq5" style="background-color:#fffaf0;"></div> | ||
==See Also== | |||
*[[Antibody 3D structures|Antibody 3D structures]] | |||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Camelidae]] | [[Category: Camelidae]] | ||
[[Category: Clostridioides difficile]] | |||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Chen | [[Category: Chen P]] | ||
[[Category: Jin | [[Category: Jin R]] | ||
[[Category: Lam | [[Category: Lam K]] | ||
Latest revision as of 10:15, 11 October 2023
Structure of the full-length Clostridium difficile toxin B in complex with 3 VHHsStructure of the full-length Clostridium difficile toxin B in complex with 3 VHHs
Structural highlights
FunctionPublication Abstract from PubMedClostridium difficile is an opportunistic pathogen that establishes in the colon when the gut microbiota are disrupted by antibiotics or disease. C. difficile infection (CDI) is largely caused by two virulence factors, TcdA and TcdB. Here, we report a 3.87-A-resolution crystal structure of TcdB holotoxin that captures a unique conformation of TcdB at endosomal pH. Complementary biophysical studies suggest that the C-terminal combined repetitive oligopeptides (CROPs) domain of TcdB is dynamic and can sample open and closed conformations that may facilitate modulation of TcdB activity in response to environmental and cellular cues during intoxication. Furthermore, we report three crystal structures of TcdB-antibody complexes that reveal how antibodies could specifically inhibit the activities of individual TcdB domains. Our studies provide novel insight into the structure and function of TcdB holotoxin and identify intrinsic vulnerabilities that could be exploited to develop new therapeutics and vaccines for the treatment of CDI. Structure of the full-length Clostridium difficile toxin B.,Chen P, Lam KH, Liu Z, Mindlin FA, Chen B, Gutierrez CB, Huang L, Zhang Y, Hamza T, Feng H, Matsui T, Bowen ME, Perry K, Jin R Nat Struct Mol Biol. 2019 Jul 15. pii: 10.1038/s41594-019-0268-0. doi:, 10.1038/s41594-019-0268-0. PMID:31308519[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
|